PapersTrialsTopicsCompoundsCountriesStakeholdersPeopleCoursesEvents
Browse all papers

Latest papers

Long-term efficacy of psilocybin with adjunct psychotherapy in treatment-resistant depressionPsilocybin · Treatment-resistant depressionDrug-drug interactions between psychiatric medications and MDMA or psilocybinMDMA & psilocybin · SafetyAn international mega-analysis of psychedelic drug effects on brain circuit functionCross-compound · NeuroimagingEsketamine in treatment-resistant depression with and without comorbid borderline personalityEsketamine · Treatment-resistant depression

Featured

Road to Access

Science, regulation, and economics on the path to patient access.

01Evidence02Approval03Reimbursement04Delivery05Access—Big Picture
Start the journey
ResultsCompare outcome data across trials and publications.Research SnapshotOne-page overview of trials, participants, papers, and research networks.Clinical GuidelinesTrial-anchored manuals and protocol guidance with competency mapping.Research recapsMonthly evidence summaries with key takeaways.Map of researchLandscape view of trials, compounds, and outcomes.NewsletterWeekly or daily updates on trials, publications, analysis, and more.Research GroupsWorldwide map of psychedelic research centres by region.Research NetworkInteractive co-authorship map of psychedelic researchers.Top papersFind needles in the haystack of psychedelic research per topic.
AskBeta
Pricing
Back to journals
Academic Journal

Journal of Medicine and Life

1 Papers Indexed in Blossom

Data updated June 16, 2026

Research Footprint

Journal of Medicine and Life has 1 tracked paper indexed in Blossom (2021) from 5 authors, most often covering Ketamine, across Anxiety Disorders, Depressive Disorders and Major Depressive Disorder (MDD).

Published Papers

Open Accessindividual

The effect of ketamine on preventing postpartum depression

In a double‑blind randomised trial of 134 women undergoing scheduled caesarean section, a single 0.5 mg/kg dose of ketamine given during anaesthetic induction significantly lowered Edinburgh Postnatal Depression Scale scores at two and four weeks versus control. These findings indicate ketamine may help prevent postpartum depression, but larger studies are required to confirm efficacy and safety.

Published
January 1, 2021
Journal
Journal of Medicine and Life
Authors
Alipoor, M., Loripoor, M., Kazemi, M., Farahbakhsh, F., Sarkoohi, A.

Quick Facts

Papers Indexed
1
Publisher
Carol Davila University Press
Website
Visit

The intelligence layer for psychedelic research.

Company

  • About
  • Contact
  • Newsletter

Product

  • Feedback
  • Roadmap
  • Changelog
  • API
  • Partners
  • Clinical Guidelines

Legal

  • Privacy
  • Terms

© 2026 Blossom. All rights reserved.